DATE [JIAYUAN.COM INTERNATIONAL] 20-F: FORM 20-F (Mark One) o OR x OR

[FORM 20-F (Mark One) o OR x OR o OR o Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . . For the transition period from to Jiayuan.com International Ltd. Not Applicable Cayman Islands (Jurisdiction of incorporation or organization) 15/F, Anhua Development Building] [As of March 31, 2015 Wholly-Owned Subsidiaries 1. Harper Capital Inc., a British Virgin Islands company 2. Jiayuan Hong Kong Corporation Limited, a Hong Kong company 3. Miyuan (Shanghai) Information Technology Co., Ltd., a PRC company 4. Beijing Miyuan Information Technology Co., Ltd., a PRC company 5. Shanghai Huaqianshu Information Technology Co., Ltd., a PRC company 6. Beijing Huaqianshu Information] [Certification by the Chief Executive Officer I, Linguang Wu, certify that: 1. I have reviewed this annual report on Form 20-F of Jiayuan.com International Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Financial Officer I, Shang-Hsiu Koo, certify that: 1. I have reviewed this annual report on Form 20-F of Jiayuan.com International Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Executive Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Linguang Wu Chief Executive Officer EX-13.1 5 a15-2912_1ex13d1.htm SECTION 906 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER] [Certification by the Chief Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Shang-Hsiu Koo Chief Financial Officer EX-13.2 6 a15-2912_1ex13d2.htm SECTION 906 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (Nos. 333-177877 and 333-184079) of Jiayuan.com International Ltd., of our report dated April 16, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. Beijing, the People’s] [April 16, 2015 Jiayuan.com International Ltd. 15/F, Anhua Development Building No. 35 Anding Road Chaoyang District, Beijing 100029 People’s Republic of China Ladies and Gentlemen: SEC Annual Report Yours faithfully, Zhong Lun Law Firm EX-15.2 8 a15-2912_1ex15d2.htm CONSENT OF ZHONG LUN LAW FIRM] [Consent of iResearch Consulting Group April 2, 2015 Jiayuan.com International Ltd. 15/F Anhua Development Building No. 35 Anding Road Chaoyang District, Beijing The People’s Republic of China Ladies and Gentlemen: iResearch Consulting Group hereby consents to references to its name in the annual report on Form 20-F of Jiayuan.com International Ltd. (the “Company”) for the fiscal year ended December 31,] [Our ref JUH/660390-000001/8046428v2 Direct tel +852 3690-7431 E-mail juno.huang@maplesandcalder.com Jiayuan.com International Ltd. 15 th Floor, Anhua Development Building No.35 An Ding Road Chao Yang District Beijing, China 16 April 2015 Dear Sir Jiayuan.com International Ltd. (the “Company”) Company Form 20-F We have acted as legal advisers as to the laws of the Cayman Islands to Jiayuan.com International Ltd. an exempted]

By | 2016-03-27T17:05:41+00:00 April 16th, 2015|Categories: Chinese Stocks, DATE, Webplus ver|Tags: , , , , , |0 Comments
Read More

HNP [HUANENG POWER INTERNATIONAL] 20-F: (Original Filing)

[_______________________ FORM 20-F (Mark One) ¨ OR þ OR ¨ OR ¨ Date of event requiring this shell company report For the transaction period form _______to ______________ HUANENG POWER INTERNATIONAL, INC. PEOPLE’S REPUBLIC OF CHINA (Jurisdiction of incorporation or organization) HUANENG BUILDING 6 FUXINGMENNEI STREET, XICHENG DISTRICT, BEIJING, PEOPLE’S REPUBLIC OF CHINA Mr. Du Daming HUANENG BUILDING, 6 FUXINGMENNEI STREET,] [Articles of Association of Huaneng Power International, Inc. Chapter 1 Article 1 Opinions on Standards for Joint Stock Limited Companies Company Law of the People's Republic of China Securities Law of the People's Republic of China Special Regulations on the Overseas Offering and Listing of Shares by Joint Stock Limited Companies promulgated by the State Council Mandatory Provisions for the] [List of Subsidiaries A list of Huaneng Power International Inc.'s subsidiaries is provided in Note 9 to the consolidated financial statements included in this annual report following Item 19.] [CERTIFICATION I, Cao Peixi, certify that: 1. I have reviewed this annual report on Form 20-F of Huaneng Power International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zhou Hui, certify that: 1. I have reviewed this annual report on Form 20-F of Huaneng Power International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. Section 1350, Section 906 of the Sarbanes-Oxley Act of 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.1 6 ex13-1.htm CERTIFICATION]

By | 2016-03-21T11:03:07+00:00 April 16th, 2015|Categories: Chinese Stocks, HNP, SEC Original|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] IRANNOTICE: (Original Filing)

[Iran Notice Re: Notice of Disclosure Filed in Annual Report on Form 20-F Under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act 100 F Street, N.E. Dear Sirs: Sincerely yours, Alex Lung Chief Financial Officer IRANNOTICE 1 v406536_iran.htm IRANNOTICE]

By | 2016-03-29T00:05:58+00:00 April 16th, 2015|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments
Read More

HNP [HUANENG POWER INTERNATIONAL] 20-F: _______________________ FORM 20-F (Mark One) ¨ OR þ

[_______________________ FORM 20-F (Mark One) ¨ OR þ OR ¨ OR ¨ Date of event requiring this shell company report For the transaction period form _______to ______________ HUANENG POWER INTERNATIONAL, INC. PEOPLE’S REPUBLIC OF CHINA (Jurisdiction of incorporation or organization) HUANENG BUILDING 6 FUXINGMENNEI STREET, XICHENG DISTRICT, BEIJING, PEOPLE’S REPUBLIC OF CHINA Mr. Du Daming HUANENG BUILDING, 6 FUXINGMENNEI STREET,] [Articles of Association of Huaneng Power International, Inc. Chapter 1 Article 1 Opinions on Standards for Joint Stock Limited Companies Company Law of the People's Republic of China Securities Law of the People's Republic of China Special Regulations on the Overseas Offering and Listing of Shares by Joint Stock Limited Companies promulgated by the State Council Mandatory Provisions for the] [List of Subsidiaries A list of Huaneng Power International Inc.'s subsidiaries is provided in Note 9 to the consolidated financial statements included in this annual report following Item 19.] [CERTIFICATION I, Cao Peixi, certify that: 1. I have reviewed this annual report on Form 20-F of Huaneng Power International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zhou Hui, certify that: 1. I have reviewed this annual report on Form 20-F of Huaneng Power International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. Section 1350, Section 906 of the Sarbanes-Oxley Act of 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.1 6 ex13-1.htm CERTIFICATION]

By | 2016-03-21T11:04:10+00:00 April 16th, 2015|Categories: Chinese Stocks, HNP, Webplus ver|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] IRANNOTICE: Iran Notice Re: Notice of Disclosure Filed in

[Iran Notice Re: Notice of Disclosure Filed in Annual Report on Form 20-F Under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act 100 F Street, N.E. Dear Sirs: Sincerely yours, Alex Lung Chief Financial Officer IRANNOTICE 1 v406536_iran.htm IRANNOTICE]

By | 2016-03-29T00:06:51+00:00 April 16th, 2015|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 20-F: (Original Filing)

[Table of Contents INTRODUCTION 3 PART I. 4 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 4 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 4 ITEM 3. KEY INFORMATION 4 ITEM 4. INFORMATION ON THE COMPANY 32 ITEM 4A. UNRESOLVED STAFF COMMENTS 54 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 54 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES] [Country of Name of Company Incorporation and Operation Shareholding Principal Activities Shenzhen Mindray Bio-Medical Electronics Co., Ltd. PRC MR Investments (HK) Limited: 88.918828% MR Holdings (HK) Limited: 11.081086% Non-controlling interest:0.000087%* Manufacturing and sales of medical equipment, research and development of related products and investment holding Shenzhen Mindray Investment & Development Co., Ltd. PRC Shenzhen Mindray Bio-Medical Electronics Co., Ltd.:99% Nanjing] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Cheng Minghe, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Alex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION Li Xiting Executive Chairman of the Board of Directors, President and Co-Chief Executive Officer Cheng Minghe Co-Chief Executive Officer and Chief Strategic Officer Alex Lung Chief Financial Officer] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-178896) of Mindray Medical International Limited of our report dated April 16, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. We also consent to]

By | 2016-03-29T00:10:01+00:00 April 16th, 2015|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 20-F: Table of Contents INTRODUCTION 3 PART I. 4

[Table of Contents INTRODUCTION 3 PART I. 4 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 4 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 4 ITEM 3. KEY INFORMATION 4 ITEM 4. INFORMATION ON THE COMPANY 32 ITEM 4A. UNRESOLVED STAFF COMMENTS 54 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 54 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES] [Country of Name of Company Incorporation and Operation Shareholding Principal Activities Shenzhen Mindray Bio-Medical Electronics Co., Ltd. PRC MR Investments (HK) Limited: 88.918828% MR Holdings (HK) Limited: 11.081086% Non-controlling interest:0.000087%* Manufacturing and sales of medical equipment, research and development of related products and investment holding Shenzhen Mindray Investment & Development Co., Ltd. PRC Shenzhen Mindray Bio-Medical Electronics Co., Ltd.:99% Nanjing] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Cheng Minghe, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Alex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION Li Xiting Executive Chairman of the Board of Directors, President and Co-Chief Executive Officer Cheng Minghe Co-Chief Executive Officer and Chief Strategic Officer Alex Lung Chief Financial Officer] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-178896) of Mindray Medical International Limited of our report dated April 16, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. We also consent to]

By | 2016-03-29T00:11:38+00:00 April 16th, 2015|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] 8-K: (Original Filing)

[Cooperation Agreement on Transfer of Source Plasma and Plasma Ingredients I+II+III Sediments for Producing Blood Products This Agreement is entered into in the city of Beijing on September 30, 2014 by and between: Party A (Supplier): Xinjiang Deyuan Bioengineering Co., Ltd. Party B (Receiver): Guizhou Taibang Biological Products Co., Ltd. WHEREAS: PRC 1. Both parties are established in good standing] [Supplemental Agreement to Cooperation Agreement on Transfer of Source Plasma and Plasma Ingredients I+II+III Sediments for Producing Blood Products This Supplemental Agreement is entered into on April 16, 2015 by and between: Party A (Supplier): Xinjiang Deyuan Bioengineering Co., Ltd; Party B (Receiver): Guizhou Taibang Biological Products Co., Ltd Any term not otherwise defined herein shall have the meaning ascribed] [FOR RELEASE April 16, 2015 China Biologic Receives Approval to Purchase Raw Materials BEIJING, China – April 16, 2015 – These raw materials are expected to be delivered during the second quarter of 2015, and the final purchase volume is contingent upon the Company's quality inspection of these raw materials. The Company expects that the final products made from such] []

By | 2016-03-25T04:42:54+00:00 April 16th, 2015|Categories: CBPO, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar